INSIGHTS ON PHARMACEUTICAL PACKAGING
-
FAQs On The Revised EU GMP Annex 1: Volume 2
Review the implementation of a holistic Contamination Control Strategy (CCS). Discover four key considerations for assessing component readiness: product, process, protection, and proof.
-
Enabling Complex Phase IIa Dosing Through Flexible Clinical Packaging Design
Discover how flexible, patient‑centric clinical packaging supports complex Phase IIa dosing while protecting timelines, ensuring compliance, and avoiding costly primary packaging changes.
-
Ophthalmic Product Package Inspection
Microscopic leaks in ophthalmic packaging can compromise sterility and patient safety. Learn how advanced vacuum decay testing delivers fast, reliable results, detecting defects as small as 5 microns.
-
The Future Of Pharma Packaging Trends, Technologies, And Patient-Centric Solutions
Pharmaceutical packaging must evolve alongside drug development to ensure stability, safety, and regulatory adherence, utilizing innovative designs to improve therapeutic outcomes and patient accessibility.
-
Designing Robust Studies To Meet Auto-Injector Performance Requirements10/30/2025
Learn more about the critical tests for ensuring the proper performance of auto-injectors, which are used for a variety of applications ranging from emergency use to treating chronic conditions.
-
Helium Leak Detection On Glass Cartridge Containers1/5/2026
Helium leak detection offers unmatched sensitivity for verifying glass cartridge seal integrity. Learn how this advanced method outperforms traditional tests and provides confidence in packaging.
-
Evaluating The Entire Package System Under USP 3825/18/2026
USP 382 introduces holistic packaging evaluation, focusing on container closure integrity, functionality, and real-world conditions to ensure sterility, safety, and product reliability.
-
Secondary Packaging: Labeling, Cartoning, Clamshell, And Stretch Carding6/23/2026
Tight timelines and coordinated packaging execution drove a high-stakes product launch ahead of a national competitor, ultimately capturing over half the market and setting a new benchmark.
-
Start Packaging Development Early: De-Risk Before You Build8/31/2026
When packaging development follows fill/finish line selection rather than informing it, teams face avoidable retrofits and delays. This article examines why earlier alignment changes outcomes.
PHARMACEUTICAL PACKAGING SOLUTIONS
-
We are the exclusive manufacturing partner for this innovative auto-injector platform.
-
Speed up your time to market and reduce your risk of selecting individual components that may not work well together by choosing the Ready Pack containment solution.
-
Examine a dual‑mode approach that delivers precise, repeatable detection for both micro‑defects and larger breaches. Strengthen packaging quality and reduce investigation cycles with this platform.
-
PCI is committed to supporting clients at every stage of the clinical cycle, delivering best-in-class services efficiently and effectively. We deliver a seamless clinical service including pharmaceutical development, clinical manufacturing, labeling, storage and distribution.
-
Large volume humidifiers and nebulizers – typically in sizes from 250 – 1000mL – can be specifically designed to fit existing delivery devices. Custom designs to facilitate the control of humidification in oxygen delivery can be developed.